March 27, 2018—A trio of new reports out this past week indicates that the historic rise in prescription drug prices in the U.S. continues and the American public is concerned. First, a report by Axios found the prices of the top 20 drugs … [Read More...]
Faces of 340B: “I Just Started Crying”
Print ArticleMarch 20, 2018—For Kathleen Cavanagh of Caldwell, Idaho, finding the 340B program was a momentous event that she describes as a “happy accident.” With a host of serious medical conditions, including type 1 diabetes, asthma, high blood pressure, and bipolar disorder, Kathleen was reliant on various prescription assistance programs to help pay the high […]
PhRMA-Funded Study Contradicts Its Conclusions
Print ArticleMarch 19, 2018 – A new PhRMA-funded study released by Milliman suggests that 340B hospitals have higher drug spending for commercially insured patients than non-340B hospitals and claims that it is the result of inappropriate drug use. However, methodological flaws in the study raise serious questions about the findings. In fact, Milliman’s report includes […]
